Literature DB >> 15966959

An exploratory study of assertive community treatment for people with intellectual disability and psychiatric disorders: conceptual, clinical, and service issues.

G Martin1, H Costello, M Leese, M Slade, N Bouras, S Higgins, G Holt.   

Abstract

BACKGROUND: Assertive community treatment (ACT) has been applied to a number of disorders in the adult population, such as schizophrenia, with some degree of success; its use in the treatment of people with intellectual disability (ID) and mental illness has received little attention. Despite the high costs of ID in health and social care, there has been very little evidence-based practice for people with ID and mental illness, and it remains a neglected area of research. Aims The aims of this study were an exploratory comparison of the effectiveness of an ACT model for the treatment of mental illness in people with ID (ACT-ID) with a standard community treatment (SCT-ID) approach.
METHOD: A Randomized controlled trial design was adopted and allocation was made by stratified randomization by an independent statistician. The prognostic factors used in the randomization were gender and psychiatric diagnosis (psychosis vs. affective). Service users were randomly allocated to either ACT-ID or SCT-ID.
RESULTS: There were no statistically significant differences between ACT-ID and SCT-ID in terms of the level of unmet needs, carer burden, functioning and quality of life, but borderline evidence of a difference between treatment groups in quality of life in favour of SCT-ID. Both SCT-ID and ACT-ID groups decreased level of unmet needs and carer burden, and increased functioning. SCT-ID also led to a small increase in quality of life.

Entities:  

Mesh:

Year:  2005        PMID: 15966959     DOI: 10.1111/j.1365-2788.2005.00709.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  8 in total

Review 1.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 2.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Hanna Bergman; Mariam A Khokhar; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2017-01-06

Review 3.  Pervasive developmental disorders and psychosis.

Authors:  Jean Starling; David Dossetor
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

Review 4.  Treatment models for treating patients with combined mental illness and developmental disability.

Authors:  Ervin Davis; L Jarrett Barnhill; Sy Atezaz Saeed
Journal:  Psychiatr Q       Date:  2008-08-23

5.  A Case of Treatment Resistant Depression and Alcohol Abuse in a Person with Mental Retardation: Response to Aripiprazole and Fluvoxamine Therapy upon Consideration of a Bipolar Diathesis after Repetitive Failure to Respond to Multiple Antidepressant Trials.

Authors:  Michele Fornaro; Giovanni Ciampa; Nicola Mosti; Alessandra Del Carlo; Giuseppe Ceraudo; Salvatore Colicchio
Journal:  Case Rep Med       Date:  2011-01-17

6.  The quality of life among persons with severe mental illness enrolled in an assertive community treatment program in Japan: 1-year follow-up and analyses.

Authors:  Masaaki Nisihio; Iwao Oshima; Junichiro Ito; Hiroo Matsuoka; Kazumi Tsukada; Kentaro Horiuchi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-07-31

7.  Clinical and cost evaluation of intensive support team (IST) models for adults with intellectual disabilities who display challenging behaviour: a comparative cohort study protocol.

Authors:  Angela Hassiotis; Athanasia Kouroupa; Rebecca Jones; Nicola Morant; Ken Courtenay; Ian Hall; Vicky Crossey; Renee Romeo; Laurence Taggart; Peter Langdon; Victoria Ratti; Vincent Kirchner; Brynmor Lloyd-Evans
Journal:  BMJ Open       Date:  2021-03-30       Impact factor: 2.692

Review 8.  Organising healthcare services for persons with an intellectual disability.

Authors:  Robert Balogh; Carly A McMorris; Yona Lunsky; Helene Ouellette-Kuntz; Laurie Bourne; Angela Colantonio; Daniela C Gonçalves-Bradley
Journal:  Cochrane Database Syst Rev       Date:  2016-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.